VRAX NASDAQ
Virax Biolabs Group Limited
1W: -8.3%
1M: -13.7%
3M: -29.3%
YTD: +472.9%
1Y: +255.2%
3Y: -29.0%
$2.20
-0.04 (-1.79%)
Weekly Expected Move ±9.1%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$8M
+29.5% ▲
5Y CAGR: +145.1%
Total Liabilities
$990K
+2.6% ▲
5Y CAGR: +2.6%
Shareholders Equity
$8M
+33.0% ▲
Cash & Investments
$7M
+54.1% ▲
5Y CAGR: +226.3%
Total Debt
$414K
+9.9% ▲
5Y CAGR: +18.2%
Net Debt
-$6M
-56.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $22K | $9M | $4M | $4M | $6M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $79K |
| Cash & ST Investments | $22K | $9M | $4M | $4M | $7M |
| Net Receivables | $0 | $0 | $218K | $31K | $0 |
| Inventory | $21K | $24K | $60K | $95K | $48K |
| Other Current Assets | $0 | $0 | $77K | $0 | $27K |
| Total Current Assets | $49K | $10M | $4M | $5M | $7M |
| Property, Plant & Equip. | $0 | $0 | $1M | $2M | $1M |
| Goodwill & Intangibles | $0 | $178K | $50K | $40K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | -$178K | -$50K | -$40K | $0 |
| Total Non-Current Assets | $0 | $178K | $1M | $2M | $1M |
| Total Assets | $49K | $10M | $5M | $6M | $8M |
| — Liabilities — | |||||
| Accounts Payable | $846K | $160K | $46K | $56K | $52K |
| Short-Term Debt | $0 | $146K | $0 | $32K | $28K |
| Deferred Revenue | -$0 | $38K | $0 | $0 | $0 |
| Other Current Liabilities | $4K | $140K | $63K | $60K | $85K |
| Total Current Liabilities | $1M | $908K | $169K | $673K | $685K |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $176K | $292K | $305K |
| Total Liabilities | $1M | $908K | $345K | $965K | $990K |
| — Equity — | |||||
| Common Stock | $999 | $2K | $3K | $4K | $14K |
| Retained Earnings | -$6M | -$12M | -$19M | -$25M | -$30M |
| Accumulated OCI | $5M | $21M | $24M | $30M | $37M |
| Total Stockholders Equity | -$975K | $9M | $5M | $6M | $8M |
| Total Liabilities & Equity | $49K | $10M | $5M | $6M | $8M |
| — Key Metrics — | |||||
| Total Debt | $4K | $146K | $224K | $377K | $414K |
| Net Debt | -$18K | -$9M | -$3M | -$4M | -$6M |
| Total Investments | $0 | $0 | $0 | $0 | $79K |